St. Vincent's University Hospital and Dublin Academic Medical Centre, Dublin, Ireland.
Mater Misericordiae University Hospital and Dublin Academic Medical Centre, Dublin, Ireland.
Arthritis Rheumatol. 2015 Sep;67(9):2447-56. doi: 10.1002/art.39217.
Giant cell arteritis (GCA) is pathologically characterized by dysfunctional angiogenesis and inflammatory cell infiltration. Acute-phase serum amyloid A (A-SAA) is an acute-phase reactant, but is also produced at sites of inflammation and may contribute to vascular inflammation in atherosclerosis. This study was undertaken to examine the effect of A-SAA on proinflammatory pathways and angiogenesis in GCA, using a novel ex vivo temporal artery tissue explant model.
Serum A-SAA levels were measured by enzyme-linked immunosorbent assay (ELISA). Temporal artery explants and peripheral blood mononuclear cell (PBMC) cultures were established from patients with GCA. Temporal artery explant morphology, viability, and spontaneous release of proinflammatory mediators following 24-hour culture were assessed by hematoxylin and eosin, calcein viability staining, and ELISA. Temporal artery explants and PBMC cultures were stimulated with A-SAA (10 μg/ml), and interleukin-6 (IL-6), IL-8, vascular endothelial growth factor, Ang2, and matrix metalloproteinase 2 (MMP-2)/MMP-9 were quantified by ELISA and gelatin zymography. The effect of conditioned medium from temporal artery explants on angiogenesis was assessed using endothelial cell Matrigel tube-formation assays. Temporal artery explants were also embedded in Matrigel, and myofibroblast outgrowth was assessed.
Serum A-SAA levels were significantly higher in GCA patients versus healthy controls (P < 0.0001). Intact tissue morphology, cell viability, and spontaneous cytokine secretion were demonstrated in temporal artery explants. A-SAA treatment induced a significant increase in the levels of IL-6 and IL-8 from temporal artery explants (P < 0.05) and IL-8 from PBMCs (P < 0.05) compared to basal conditions. Conditioned medium from A-SAA-treated explants significantly induced angiogenic tube formation (P < 0.05 versus basal controls). Finally, A-SAA induced myofibroblast outgrowth and MMP-9 activation.
Our findings demonstrate a functional role for A-SAA in regulating temporal artery inflammation, angiogenesis, and invasion, all key processes in the pathogenesis of GCA.
巨细胞动脉炎(GCA)的病理学特征为功能失调的血管生成和炎症细胞浸润。急性期血清淀粉样蛋白 A(A-SAA)是一种急性期反应物,但也在炎症部位产生,并可能导致动脉粥样硬化中的血管炎症。本研究采用新型颞动脉组织外植体模型,研究 A-SAA 对 GCA 中前炎症途径和血管生成的影响。
通过酶联免疫吸附试验(ELISA)测量血清 A-SAA 水平。从 GCA 患者中建立颞动脉外植体和外周血单核细胞(PBMC)培养物。通过苏木精和伊红、钙黄绿素活力染色和 ELISA 评估 24 小时培养后颞动脉外植体形态、活力和自发性释放前炎症介质的情况。用 A-SAA(10μg/ml)刺激颞动脉外植体和 PBMC 培养物,通过 ELISA 和明胶酶谱法定量测定白细胞介素 6(IL-6)、白细胞介素 8(IL-8)、血管内皮生长因子、Ang2 和基质金属蛋白酶 2(MMP-2)/MMP-9。通过内皮细胞 Matrigel 管形成测定评估来自颞动脉外植体的条件培养基对血管生成的影响。还将颞动脉外植体嵌入 Matrigel 中,评估肌成纤维细胞的生长情况。
GCA 患者的血清 A-SAA 水平明显高于健康对照组(P<0.0001)。颞动脉外植体显示完整的组织形态、细胞活力和自发性细胞因子分泌。与基础条件相比,A-SAA 处理诱导颞动脉外植体中 IL-6 和 IL-8 水平显著升高(P<0.05),并诱导 PBMC 中 IL-8 水平升高(P<0.05)。来自 A-SAA 处理的外植体的条件培养基显著诱导血管生成管形成(P<0.05 与基础对照相比)。最后,A-SAA 诱导肌成纤维细胞生长和 MMP-9 激活。
我们的研究结果表明 A-SAA 在调节颞动脉炎症、血管生成和浸润方面具有功能作用,这些都是 GCA 发病机制中的关键过程。